DJIA 16,262.56 0.00 0.00%
NASDAQ 4,034.16 0.00 0.00%
S&P 500 1,842.98 0.00 0.00%
market minute promo



139.84 0.00 (0.00%)

REAL-TIME: Last trade at

Extended Hours: $141.01 $1.17 (0.84%)
Quote as of (NASDAQ)

company name or ticker

Recent Quotes

CELG $139.84 0.00%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $139.03
Previous Close $139.84
Daily Range $133.70 - $140.95
52-Week Range $110.53 - $174.66
Market Cap $56.8B
P/E Ratio 40.97
Dividend (Yield) $0.00 (0.0%)
Volume 4,214,464
Average Daily Volume 4,445,686
Current FY EPS $6.34





Celgene (CELG) Description

A biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases. Website:

News & Commentary

Can Celgene Deliver in 2014?

Celgene (NASDAQ: CELG) had a strong 2013, but 2014 is not quite going to plan. Can it turn things around?

Gilead: This Baby Has Been Thrown Away With The Bathwater

Anacor Pharma Remains Over-Valued on Development of Inferior Drugs

Stock Market News for April 14, 2014 - Market News

Celgene Growth Unappreciated In Recent Sell-Off

3 Stocks Reiterated As A Buy: CAT, CELG, CMCSA

Stock Market News for April 11, 2014 - Market News

3 Drugs Stocks Driving The Industry Higher

Today's Market: Playing The Biotech Bloodbath

Three Biotech Companies That Look To Be Good Buys After A Pullback

Tech stock rout continues in Asia

Asia tech stocks fall into the red

See More CELG News...

CELG's Top Competitors

CELG $139.84 (0.00%)
Current stock: CELG
AMGN $115.00 (0.00%)
Current stock: AMGN
GILD $68.17 (0.00%)
Current stock: GILD
$0.00 (0.00%)
Current stock: